Imperial College London

Dr Kelly Seo

Faculty of MedicineDepartment of Surgery & Cancer

Honorary Research Associate







Sir Alexander Fleming BuildingSouth Kensington Campus





Kelly Seo (also known as Mikyung Kelly Seo), PhD, is a health economist at Imperial College London for the NIHR London In Vitro Diagnostics Co-operative. She is an experienced health economist, having worked for international organizations (International Labor Organization (ILO, Geneva) and the International Vaccine Institute (IVI, Seoul)) and consultancies. She holds a PhD in health economics from the London School of Hygiene and Tropical Medicine (LSHTM). Her PhD thesis was on economic evaluations of companion biomarkers for targeted therapies in cancer. She also holds an MSc in health policy, planning and financing from the London School of Economics (LSE) and LSHTM.


Kelly's research interests are primarily in the cost-effectiveness of interventions to improve public health across a range of health technologies, disease areas, and population groups. Her research areas include:

  • Economic evaluations.
  • Decision-analytic modelling.
  • Health technology assessment (HTA).
  • Survival analysis.
  • Care pathway analysis.
  • Value of information analysis.
  • Econometrics.
  • Systematic literature review and meta-analysis.
  • Budget impact analysis.

Selected Publications

Journal Articles

Seo MK, Strong M, 2021, A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper., Pharmacoeconomics, Vol:39, Pages:1373-1381

Seo MK, Cairns J, 2021, How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review., BMC Cancer, Vol:21, ISSN:1471-2407

Micocci M, Gordon AL, Seo MK, et al., 2021, Is point-of-care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a point-of-care polymerase chain reaction test for SARS-CoV-2, Age and Ageing, Vol:50, ISSN:0002-0729, Pages:1464-1472

Luis ABD, Seo MK, 2021, Has the development of cancer biomarkers to guide treatment improved health outcomes?, European Journal of Health Economics, Vol:22, ISSN:1618-7598, Pages:789-810

Seo MK, Straume O, Akslen LA, et al., 2020, HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?, Pharmacoeconomics-open, Vol:4, ISSN:2509-4262, Pages:529-539

Seo MK, Cairns J, 2018, Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer., PLOS One, Vol:13, ISSN:1932-6203, Pages:1-23

Seo MK, Baker P, Karen N-LN, 2014, Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets, Malaria Journal, Vol:13, ISSN:1475-2875

More Publications